Sarah Guimbal

Sarah Guimbal

Auto-generated profile, based on publicly available information

Sarah Guimbal

Institut National de la Santé et de la Recherche Médicale (INSERM) U1034, Biology of Cardiovascular Diseases, University of Bordeaux, Pessac, France (P.R., S.G., L.C., C.B., N.F., P.A., C.C., A.-P.G., T.C., M.-A.R.).

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Cardiovascular Research
Verified
Journal Article
Closed access
PHPierre-Louis Hollier
Pierre-Louis Hollier
CCCandice Chapouly
Candice Chapouly
ADAissata Diop
Aissata Diop
SGSarah Guimbal
Sarah Guimbal
LCLauriane Cornuault
Lauriane Cornuault
MRMarie-Ange Renault
Marie-Ange Renault
Aims: The therapeutic potential of Hedgehog (Hh) signalling agonists for vascular diseases is of growing interest. However, molecular and cellular mechanisms underlying the role of the Hh signalling in vascular biology remain poorly understood. The purpose of the present article is to clarify some conflicting literature data. Methods and results: With this goal, we have demonstrated that, unexpectedly, ectopically administered N-terminal Sonic Hh (N-Shh) and endogenous endothelial-derived Desert Hh (Dhh) induce opposite effects in endothelial cells (ECs). Notably, endothelial Dhh acts under its full-length soluble form (FL-Dhh) and activates Smoothened in ECs, while N-Shh inhibits it. At molecular level, N-Shh prevents FL-Dhh binding to Patched-1 (Ptch1) demonstrating that N-Shh acts as competitive antagonist to FL-Dhh. Besides, we found that even though FL-Hh ligands and N-Hh ligands all bind Ptch1, they induce distinct Ptch1 localization. Finally, we confirmed that in a pathophysiological setting, i.e. brain inflammation, astrocyte-derived N-Shh acts as a FL-Dhh antagonist. Conclusion: The present study highlights for the first time that FL-Dhh and N-Hh ligands have antagonistic properties especially in ECs.

1 January 2024 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PRPaul Rouault
Paul Rouault
SGSarah Guimbal
Sarah Guimbal
LCLauriane Cornuault
Lauriane Cornuault
CBCélia Bourguignon
Célia Bourguignon
NFNinon Foussard
Ninon Foussard
MRMarie-Ange Renault
Marie-Ange Renault
BACKGROUND: Heart failure with preserved ejection fraction is proposed to be caused by endothelial dysfunction in cardiac microvessels. Our goal was to identify molecular and cellular mechanisms underlying the development of cardiac microvessel disease and diastolic dysfunction in the setting of type 2 diabetes. METHODS: We used Lepr db/db (leptin receptor–deficient) female mice as a model of type 2 diabetes and heart failure with preserved ejection fraction and identified Hhipl1 (hedgehog interacting protein-like 1), which encodes for a decoy receptor for HH (hedgehog) ligands as a gene upregulated in the cardiac vascular fraction of diseased mice. RESULTS: We then used Dhh (desert HH)-deficient mice to investigate the functional consequences of impaired HH signaling in the adult heart. We found that Dhh -deficient mice displayed increased end-diastolic pressure while left ventricular ejection fraction was comparable to that of control mice. This phenotype was associated with a reduced exercise tolerance in the treadmill test, suggesting that Dhh -deficient mice do present heart failure. At molecular and cellular levels, impaired cardiac relaxation in Dhh ECKO mice was associated with a significantly decreased PLN (phospholamban) phosphorylation on Thr17 (threonine 17) and an alteration of sarcomeric shortening ex vivo. Besides, as expected, Dhh -deficient mice exhibited phenotypic changes in their cardiac microvessels including a prominent prothrombotic phenotype. Importantly, aspirin therapy prevented the occurrence of both diastolic dysfunction and exercise intolerance in these mice. To confirm the critical role of thrombosis in the pathophysiology of diastolic dysfunction, we verified Lepr db/db also displays increased cardiac microvessel thrombosis. Moreover, consistently, with Dhh -deficient mice, we found that aspirin treatment decreased end-diastolic pressure and improved exercise tolerance in Lepr db/db mice. CONCLUSIONS: Altogether, these results demonstrate that microvessel thrombosis may participate in the pathophysiology of heart failure with preserved ejection fraction.

4 April 2026
Verified
Thesis
Closed access
SGSarah Guimbal
Sarah Guimbal
L’insuffisance cardiaque engendre un décès toutes les 7 minutes en France. Cependant, il n’existe aucun traitement pour l’insuffisance cardiaque à fraction d’éjection préservée (ICFEp) qui représente aujourd’hui 50% des cas d’insuffisance cardiaque et dont la prévalence augmente constamment avec le vieillissement de la population. Mieux comprendre l’étiologie et la physiopathologie de cette maladie est primordial pour découvrir des thérapies efficaces pour la prise en charge de cette maladie. L’objectif de cette thèse est d’explorer le rôle de la maladie des petits vaisseaux dans la physiopathologie de l’ICFEp. Plus précisément, nous nous sommes attachés (1) à mieux caractériser le phénotype des capillaires cardiaques chez des souris présentant une dysfonction diastolique, (2) à caractériser les conséquences d’une dysfonction endothéliale sur la structure et la fonction cardiaque et (3) à mieux appréhender les mécanismes moléculaires impliqués dans la régulation de l’intégrité endothéliale par la voie de signalisation Hedgehog (Hh).Nous avons démontré pour la première fois dans un modèle physiopathologique d’ICFEp que les mastocytes sont des acteurs cruciaux du développement de la maladie des microvaisseaux et de la dysfonction diastolique. Nous avons également établi qu’une dysfonction endothéliale caractérisée principalement par une augmentation de la perméabilité vasculaire peut induire une dysfonction diastolique en absence de tout autre facteur de risque cardiovasculaire. En outre, nous avons démontré que le ligand Desert Hedgehog maintient l’intégrité vasculaire en régulant la dégradation de la métalloprotéinase Adam17 dans les cellules endothéliales.L’ensemble de ces résultats démontrent le rôle crucial de la dysfonction endothéliale dans la physiopathologie de l’ICFEp, ainsi que le rôle majeur de Dhh et de la voie de signalisation Hh dans l’intégrité vasculaire notamment dans le cœur.

17 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SGSarah Guimbal
Sarah Guimbal
LCLauriane Cornuault
Lauriane Cornuault
PHPierre-Louis Hollier
Pierre-Louis Hollier
CCCandice Chapouly
Candice Chapouly
MBMarie-Lise Bats
Marie-Lise Bats
MRMarie-Ange Renault
Marie-Ange Renault
Rational: Heart failure with preserved ejection fraction (HFpEF) is a growing epidemiologic issue. However, to date, its pathophysiology remains poorly understood. Objective: Our goal was to investigate the role of microvessel disease in the pathophysiology of diastolic dysfunction. Findings: To do so, we used Leptin receptor deficient (Lepr db/db ) female mice as a model of diastolic dysfunction. In these mice, the increased end diastolic pressure (EDP) signing diastolic dysfunction is associated with vascular leakage, endothelial cell activation and leucocyte infiltration. Strikingly, a RNA sequencing analysis of the cardiac vascular fraction of both Lepr db/db and control female mice confirmed endothelial dysfunction and systemic inflammation but also revealed a strong increase in several mast cell markers (notably FceR1a, Tryptase and Chymase). We then histologically confirmed an accumulation of activated mast cells in the heart of Lepr db/db mice. Importantly, mast cell degranulation inhibition reduced EDP, vascular leakage and leucocyte infiltration in Lepr db/db mice. Conclusion: Mast cells play a critical role in the development of cardiac microvessel disease and diastolic dysfunction.